← FDA Drug Approvals (Drugs@FDA)
CLOBETASOL PROPIONATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2025-11-20
Drug application
- FDA Application #
ANDA210638- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CLOBETASOL PROPIONATE
- Generic name
- Clobetasol Propionate
- Active ingredients
- CLOBETASOL PROPIONATE
- Dosage form
- AEROSOL, FOAM
- Route
- TOPICAL
- Marketing status
- Prescription
- Sponsor
- XIROMED
- First approval
- 2025-11-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown